BAYER AG Firmenkenndaten im Überblick

Pharmaceutical Sales 2014

Worlwide: 18.657 billion EURO

Product Range

Hypertension, heart attack prevention, stroke prevention, diabetes management, bacterial infection, venous and arterial thromboembolism, haemophilia A, certain cancer diseases, pulmonary hypertension, hormone replacement therapy, contraceptives, gynecological therapy, multiple sclerosis, eye diseases

Key Research Areas BAYER AG

Bayer HealthCare Pharmaceuticals: Cardiology, Oncology, Ophthalmology, Haematology, Gynaecology

R&D Expenditure 2014

worldwide: 2.301 billion Euro (Bayer HealthCare AG)

BAYER AG Employees in the Pharmaceuticals Division 2014

worldwide: 39.069 (Bayer HealthCare Pharmaceuticals), 60.716 (Bayer HealthCare in total)
(All data based on corporate information from member BAYER AG , as of: 09/2015)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download